Skip to main content
. Author manuscript; available in PMC: 2010 Jun 1.
Published in final edited form as: Atherosclerosis. 2008 Sep 27;204(2):418–423. doi: 10.1016/j.atherosclerosis.2008.09.016

Figure 1.

Figure 1

FPLC profile showing cholesterol content (mg/dl)of plasma lipoprotein fractions from human apoA-I transgenic mice fed a Western diet (Control) or a Western diet containing nevirapine or efavirenz at (A) week 4 and (B) week 8.